Results 221 to 230 of about 231,458 (256)

B-cells in breast cancer: current insights and challenges. [PDF]

Front Oncol
Xiang B, Liu T, Xu D, Wang W.
europepmc   +1 more source

Immune cells in the pathogenesis of abdominal aortic aneurysm: Roles, regulation and targeted interventions

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
This review provides a comprehensive overview of how macrophages, neutrophils, T cells and other immune cells infiltrate the aortic wall, undergo phenotypic shifts and interact with one another in abdominal aortic aneurysm (AAA). Background Abdominal aortic aneurysm (AAA) is a lethal degenerative vascular disease with no approved clinical drugs. Immune
Junqi Peng, Hanqing Zhang, Yun Wu, Song Chen   +3 more
wiley   +1 more source

Plasmablastic Richter Transformation of Chronic Lymphocytic Leukemia With Aberrant Epithelial Marker Expression Presenting as a Pleural Effusion: A Diagnostic Challenge. [PDF]

Case Rep Pathol
Rogers J, Akhter JZ, Rosa M, Niyazi S, Werner-Idiaquez D, Pinilla-Ibarz J, Grajales-Cruz A, Moscinski L, Ryder CB.   +8 more
europepmc   +1 more source

Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive‐stage small cell lung cancer

Clinical &Translational Immunology, Volume 15, Issue 10, 2026.
Abstract Objectives Extensive‐stage small cell lung cancer (ES‐SCLC) remains an aggressive malignancy with limited durable responses to immune checkpoint inhibitors (ICIs) and no established predictive biomarkers. This study aimed to evaluate the prognostic and predictive value of tertiary lymphoid structures (TLSs) in patients with ES‐SCLC receiving ...
Haoyu Wang, Xiaoling Shang, Yuanzhu Jiang, Chenglong Zhao, Zhenxiang Li, Chufeng Zhang, Qinhao Xu, Shanshan Du, Jiamao Lin, Haiyong Wang   +9 more
wiley   +1 more source

Zamtocabtagene autoleucel: dual CD20-CD19 targeting for NHL. [PDF]

Blood Adv
Srinagesh HK, Muffly LS.
europepmc   +1 more source

Advances in Oncohematology Immunotherapy: Monoclonal Antibodies and CAR T-Cell Therapies. [PDF]

Cells
Mathias F, Fersing C, Bourgarel V, Gabert J, Peyron F.   +4 more
europepmc   +1 more source

SLV‐404, an anti‐RYK antibody–drug conjugate, is effective in Richter transformation patient‐derived xenografts

HemaSphere, Volume 10, Issue 10, October 2026.
Abstract Richter transformation (RT), a highly aggressive lymphoma arising from a preexisting chronic lymphocytic leukemia, represents a major unmet clinical need. Recent data have shown that an antibody–drug conjugate (ADC) targeting the cell‐surface pseudokinase ROR1 is effective in RT patients.
Matilde Micillo, Beatrice Pirajno, Francesco Edoardo Vallone, Victor Navarro‐Tableros, Elisabetta Bolli, Valentina Griggio, Brian J. Lannutti, Katti A. Jessen, Tiziana Vaisitti, Silvia Deaglio   +9 more
wiley   +1 more source

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas. [PDF]

Br J Haematol
Neumann F, Schormann C, Cetin O, Kos IA, Bewarder M, Schwarz EC, Lohse S, Maurer S, Staber PB, Bittenbring JT, Smola S, Christofyllakis K, Hoth M, Thurner L.   +13 more
europepmc   +1 more source

Analytical validity of CD20 as a biomarker in breast cancer patients using tissue microarrays and whole slide sections. [PDF]

Biomark Med
Özcan D, Nielsen PS, Alsner J, Tramm T.
europepmc   +1 more source

Integrated Immune Profiling Identifies Treatment-Associated Immune Patterns in Patients with B-Cell Hematological Malignancies. [PDF]

J Proteome Res
Arias-Hidalgo C, Hernández-Vazquez J, Teodosio C, Juanes-Velasco P, Nuño-Soriano A, Cal-Sabater P, Arribas-Rodríguez E, Fiz-López A, Pérez-Mazzali M, Martín-Muñoz Á, Tellería P, Vicuña MG, Gamazo-Herrero J, Fuente-Graciani I, Pérez-González S, Bravo S, García-Alonso C, Dueñas C, Peñarrubia MJ, Vigo-Aceves M, Núñez-Abascal C, Neira-González L, Gongora R, Cuesta-Sancho S, Bernardo D, Hernández ÁP, Fuentes M.   +26 more
europepmc   +1 more source